Global Cardiology Academy

Updates from ACC 2023: Examining Transcatheter Repair Study Data

ReachMD Healthcare Image

Find out how the results from the TRILUMINATE trial may reduce tricuspid regurgitation and improve quality of life.

  • Overview

    TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improvements in care and quality of life. To learn more about this trial, Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation details the key findings from this trial and explores their impact.

Facebook Comments



We’re glad to see you’re enjoying Global Cardiology Academy…
but how about a more personalized experience?

Register for free